Boothbay Fund Management’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
Other funds holding RMD
Boothbay Fund Management's RMD Position: Q3 2026 in Review
Boothbay Fund Management sold out of ResMed (RMD) in Q3 2026, closing a stake of 2,444 shares — an estimated $476K sold.
Boothbay Fund Management first reported a position in RMD in Q1 2021 and held it in 12 quarters. The position peaked at $4.07M in Q1 2021. 875 funds tracked by Wall St. Rank hold RMD as of Q3 2026.
- Boothbay Fund Management reported no remaining ResMed position as of Q3 2026 after selling out during the quarter.
- Boothbay Fund Management sold 2,444 ResMed shares in Q3 2026, an estimated $476K.
- Boothbay Fund Management first reported a position in ResMed in Q1 2021 and held it in 12 quarters.
- Boothbay Fund Management's ResMed position peaked at $4.07M in Q1 2021.
- 875 funds tracked by Wall St. Rank held ResMed as of Q3 2026.
Based on Boothbay Fund Management's 13F filing for Q3 2026, filed 16 Nov 2026.